Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001762572-26-000002
Filing Date
2026-02-19
Accepted
2026-02-19 16:21:06
Documents
1
Period of Report
2026-02-17

Document Format Files

Seq Description Document Type Size
1 form4-02192026_090202.html 4  
1 form4-02192026_090202.xml 4 6601
  Complete submission text file 0001762572-26-000002.txt   8095
Mailing Address 45 WIGGINS AVENUE BEDFORD MA 01730
Business Address 45 WIGGINS AVENUE BEDFORD MA 01730 781-430-8200
Stoke Therapeutics, Inc. (Issuer) CIK: 0001623526 (see all company filings)

EIN.: 471144582 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address STOKE THERAPEUTICS, INC. 45 WIGGINS AVENUE BEDFORD MA 01730
Business Address
Hoitt Jason (Reporting) CIK: 0001762572 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38938 | Film No.: 26654746